1-5 of 5
Monika Pogorzala
Close
Sort by
Journal Articles

Differential in Vitro Drug Resistance Profile Between First and Second Relapsed Acute Lymphoblastic Leukemia and Acute Myeloblastic Leukemia in Children

Jan Styczynski, Beata Kurylo-Rafinska, Malgorzata Kubicka, Beata Kolodziej, Monika Pogorzala, Krzysztof Czyzewski, Robert Debski, Magdalena Wisniewska, Mariusz Wysocki, Michal Matysiak, Prof., MDPhD, Iwona Malinowska, Walentyna Balwierz, Prof MDPhD, Edyta Juraszewska, Jacek Wachowiak, Benigna Konatkowska, Mariola Woszczyk, MDPhD, Igor Olejnik, MD, Maryna Krawczuk-Rybak, Prof MDPhD, Marta Kuzmicz, Jerzy Kowalczyk, Prof MDPhD, Maria Jolanta Stefaniak, MD PhD, Wanda Badowska, Tomasz Szczepanski, Prof MD PhD, Renata Tomaszewska, Elzbieta Adamkiewicz-Drozynska, Lucyna Maciejka-Kemblowska, Grazyna Sobol, Agnieszka Mizia-Malarz, Joanna Szczepanek
Journal: Blood
Blood (2015) 126 (23): 3696.
https://doi.org/10.1182/blood.V126.23.3696.3696
Published: 2015
Journal Articles

Whole Genome and Transcriptome Analysis of Genetic Alterations in Context of Busulfan in Vitro Resistance in Pediatric Acute Leukemias

Joanna Szczepanek, Krzysztof Domagalski, Joanna Laskowska, Monika Pogorzala, Andrzej Tretyn, Jan Styczynski
Journal: Blood
Blood (2015) 126 (23): 4849.
https://doi.org/10.1182/blood.V126.23.4849.4849
Published: 2015
Journal Articles

Patterns of Individual Tumor Response Testing (ITRT) and Bone Marrow Minimal Residual Disease (MRD) On Day 15 of Therapy in Childhood Precursor-B-Lineage Acute Lymphoblastic Leukemia (ALL): MRD and Ex Vivo Drug Resistance Have Similar Predictive Value of Relapse.

Jan Styczynski, MD, PhD, Anna Jaworska-Posadzy, Malgorzata Kubicka, Robert Debski, MD, PhD, Beata Kurylo-Rafinska, Beata Kolodziej, Monika Pogorzala, MD, PhD, Magdalena Piatkowska, MD, Krzysztof Czyzewski, MD, PhD, Mariusz Wysocki, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 2448.
https://doi.org/10.1182/blood.V120.21.2448.2448
Published: 2012
Journal Articles

Individualized Tumor Response Testing (ITRT) Profile Has a Prognostic Value in Childhood Acute Lymphoblastic Leukemia (ALL) and Acute Non-Lymphoblastic Leukemia (ANLL): The Multicenter Non-Interventional Long-Term Follow-up Study of Polish Pediatric Leukemia Study Group

Magdalena Piatkowska, MD, Jan Styczynski, MD, PhD, Beata Kolodziej, Beata Kurylo-Rafinska, Malgorzata Kubicka, Monika Pogorzala, MD, PhD, Krzysztof Czyzewski, MD, PhD, Robert Debski, MD, PhD, Michal Matysiak, MD, PhD, Iwona Malinowska, MD, PhD, Elzbieta Stanczak, MD, PhD, Walentyna Balwierz, MD, PhD, Edyta Juraszewska, MD, Jacek Wachowiak, Beningna Konatkowska, MD, PhD, Maria Wieczorek, MD, PhD, Igor Olejnik, MD, Maryna Krawczuk-Rybak, MD, PhD, Marta Kuzmicz, MD, Jerzy Kowalczyk, MD, PhD, Maria Jolanta Stefaniak, MD, PhD, Wanda Badowska, MD, PhD, Tomasz Szczepanski, Anna Balcerska, MD, PhD, Lucyna Maciejka-Kapuscinska, Grazyna Sobol, Agnieszka Mizia-Malarz, MD, Mariusz Wysocki, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 1456.
https://doi.org/10.1182/blood.V118.21.1456.1456
Published: 2011
Journal Articles

Gene Expression and Ex Vivo Drug Sensitivity Profiles in Children with Acute Leukemia: An Insight for High-Dose Therapy and Role of Etoposide and Fludarabine.

Joanna Szczepanek, Michal Jarzab, Malgorzata Oczko-Wojciechowska, Malgorzata Kowalska, Andrzej Tretyn, Olga Haus, Monika Pogorzala, Mariusz Wysocki, Barbara Jarzab, Jan Styczynski
Journal: Blood
Blood (2009) 114 (22): 2747.
https://doi.org/10.1182/blood.V114.22.2747.2747
Published: 2009